Navigation Links
Global Central Nervous System Drugs Market 2011-2015
Date:7/23/2012

NEW YORK, July 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Central Nervous System Drugs Market 2011-2015

http://www.reportlinker.com/p0936080/Global-Central-Nervous-System-Drugs-Market-2011-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

TechNavio's analysts forecast the Global Central Nervous System Drugs market to grow at a CAGR of -3.2 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing size of aging population. The Global EEG/EMG Equipment market has also been witnessing the trend of novel molecules, launched to treat central nervous system disorders effectively. However, patent expiration of key drugs could pose a challenge to the growth of this market.

TechNavio's report, the Global Central Nervous System Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Central Nervous System Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include AstraZeneca plc, Eli Lilly & Co., Johnson & Johnson Ltd., and Pfizer Inc. Other vendors mentioned in the report: Abbott Laboratories, Sanofi S.A., Bristol-Myers Squibb Co., Eisai Co. Ltd., UCB Pharma, Merck & Co. Inc., Schering-Plough Corp., Shire plc, and Cephalon Inc.

Key questions answered in this report:

What will the market size be in 2015 and at what rate will it grow? What key trends is this market subject to? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the opportunities and threats faced by each of these key vendors? What are the strengths and weaknesses of each of these key vendors? You can request one free hour of analyst time when you purchase this report. Details provided within the report.01. Executive Summary 02. Introduction 03. Market Coverage Overview Product Offerings 04. Market Landscape Global Central Nervous System Drugs Market Market Size Key Market Segments 04.1 Global Antipsychotics Market 04.2 Global Antidepressants Market 04.3 Global Antiepileptic Drugs Market 04.4 Global Anti-Alzheimer's Drugs Market 04.5 Global ADHD Drugs Market 04.6 Global Hypnotics Market 04.7 Global Anti-Parkinson's Drugs Market 04.8 Global Antimigraine Drugs Market Segmentation of Global Central Nervous System Drugs Market Five Forces Analysis 05. Geographical Segmentation 06. Key Leading Countries USA Japan Germany 07. Rate of Incidence and Prevalence 08. Vendor Landscape Matrix of the Product Portfolio Matrix Vendor Landscape of the Leading CNS Drugs Market Segments 08.1 Global Antipsychotics Market Segment 08.2 Global Antidepressants Market Segment 08.3 Global Antiepileptic Drugs Market Segment 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 15.1 Eli Lilly and Co. Business Overview SWOT Analysis 15.2 Pfizer Inc. Business Overview SWOT Analysis 15.3 AstraZeneca plc Business Overview SWOT Analysis 15.4 Johnson and Johnson Ltd. Business Overview SWOT Analysis 16. Other Reports in this Series

List of Exhibits:

Exhibit 1: Global Central Nervous System Drugs Market 2011-2015 (US$ billion)

Exhibit 2: Global Central Nervous System Drugs Market Segmentation 2011

Exhibit 3: Global Central Nervous System Drugs Market by Product Segmentation 2011-2015 (percent)

Exhibit 4: Global Antipsychotics Market 2011-2015 (US$ billion)

Exhibit 5: Global Antidepressants Market 2011-2015 (US$ billion)

Exhibit 6: Global Antiepileptic Drugs Market 2011-2015 (US$ billion)

Exhibit 7: Global Anti-Alzheimer's Drugs Market 2011-2015 (US$ billion)

Exhibit 8: Global Attention Deficit Hyperactivity Disorder Drugs Market 2011-2015 (US$ billion)

Exhibit 9: Global Hypnotics Market 2011-2015 (US$ billion)

Exhibit 10: Global Anti-Parkinson's Drugs Market 2011-2015 (US$ billion)

Exhibit 11: Global Antimigraine Drugs Market 2011-2015 (US$ billion)

Exhibit 12: Global Central Nervous System Market by Overall Market Segmentation (US$ billion)

Exhibit 13: Global Central Nervous System Drugs Market by Geographical Segmentation 2011

Exhibit 14: Global Central Nervous System Drugs Market by Vendor Segmentation 2011

Exhibit 15: Global Antipsychotics Market by Vendor Segmentation 2011

Exhibit 16: Global Antidepressants Market by Vendor Segmentation 2011

Exhibit 17: Global Antiepileptic Drugs Market by Vendor Segmentation 2011

To order this report:Drug and Medication Industry: Global Central Nervous System Drugs Market 2011-2015

More Market Research Report

Check our Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sysmex and Siemens Renew Global Partnership for Hemostasis Solutions and Services
2. China Health Resource Announces Go Global Initiative For New Product Introductions
3. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
4. Medica Announces Global Release of the EasyCell Assistant Analyzer for Hematology Laboratories
5. Enteral Feeding Devices Industry is Expected to Reach USD 2,447.6 Million Globally in 2018: Transparency Market Research
6. Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
7. Global Medical Device Industry 2012-2017: Trend, Profit, and Forecast Analysis
8. Global Cardiovascular Device Industry 2012-2017: Trend, Profit and Forecast Analysis
9. Science Translational Medicine and the DMM Global Foundation Announce Days of Molecular Medicine 2012 "The Translational Science of Rare Diseases: From Rare To Care."
10. 2012 Global APTT Market Outlook: Test Volume Forecasts by Country and Market Segment
11. Global Bio-Clinical Trials 2012 Just Launched in India!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... PARK, Calif. , Oct. 11, 2017  BioPharmX ... national scientific team that developed an innovative way to ... quantity of the delivery of new drugs. ... 2017 Fall Clinical Dermatology Conference will show how researchers ... General Hospital, Harvard Medical School used a suite of ...
(Date:10/11/2017)... CHICAGO , Oct. 11, 2017  Hill-Rom Holdings, ... its Aspen Surgical facility in Las Piedras, ... surgical scalpels and blades. ... confirmed that the facility sustained minor structural damage, temporary ... Hurricane Maria. Repairs have been completed, manufacturing operations have ...
Breaking Medicine Technology:
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in property taxes a year. In some states—like New York, New Jersey, Massachusetts, ... contrast, many overseas retirement havens have extremely low property-tax rates, which contributes to ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... presents its enhanced Pepper Flow promotional review platform at the Promotional Review ... increased insight-driven capabilities help marketers streamline the medical, legal, and regulatory review ...
Breaking Medicine News(10 mins):